Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Columbia University State University of New York - Upstate Medical University |
---|---|
Information provided by: | Columbia University |
ClinicalTrials.gov Identifier: | NCT00271739 |
The IDEATel study is a multicenter randomized controlled trial to evaluate the efficacy, acceptability, and cost-effectiveness of telemedicine case management to provide diabetes care to elderly Medicare beneficiaries residing in medically underserved areas of New York State.
Condition | Intervention |
---|---|
Diabetes Mellitus |
Procedure: Telemedicine diabetes case management |
Study Type: | Interventional |
Study Design: | Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study |
Official Title: | Informatics for Diabetes Education and Telemedicine (IDEATel) |
Estimated Enrollment: | 1665 |
Study Start Date: | December 2000 |
Estimated Study Completion Date: | February 2008 |
The project is designed as a randomized controlled trial with approximately 750 subjects receiving a telemedicine intervention and approximately 750 receiving usual care. Eligibility requires having diabetes, being a Medicare beneficiary, and living in a medically underserved area. The project is conducted in New York City, in northern Manhattan (urban component), and in rural upstate New York through a consortion of participating institutions based at SUNY Upstate Medical University at Syracuse (rural component). Subjects are randomized to receive telemedicine case management or usual care for diabetes. The intervention utilizes a home telemedicine unit (HTU). The HTU is a specially designed, web-enabled device with a data port connected to a home glucometer and home blood pressure cuff whereby measurements obtained with these devices can be directly uploaded to a computer database. A diabetes nurse case manager interacts regularly with intervention participants through videoconference via the HTU.
Ages Eligible for Study: | 55 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Criteria for inclusion were age 55 years or greater, being a current Medicare beneficiary (verified by the Centers for Medicare and Medicaid Services), having diabetes mellitus as defined by a physician's diagnosis and being on treatment with diet, an oral hypoglycemic agent, or insulin, residence in a federally designated medically underserved area (either of two federal designations, Medically Underserved Area [MUA] or Health Manpower Shortage Area [HPSA]) in New York Sate, and fluency in either English or Spanish.
Exclusion Criteria:
Exclusions were moderate or severe cognitive, visual, or physical impairment, or the presence of severe comorbid disease.
United States, New York | |
Columbia University | |
New York, New York, United States, 10032 | |
SUNY Upstate Medical University | |
Syracuse, New York, United States, 13210 |
Principal Investigator: | Steven Shea, MD | Columbia University |
Study ID Numbers: | CMS 95-C-90998 |
Study First Received: | December 30, 2005 |
Last Updated: | October 3, 2007 |
ClinicalTrials.gov Identifier: | NCT00271739 |
Health Authority: | United States: Institutional Review Board |
Telemedicine Diabetes Mellitus |
Metabolic Diseases Diabetes Mellitus Endocrine System Diseases |
Endocrinopathy Metabolic disorder Glucose Metabolism Disorders |